Intuitive Surgical Inc.
ISRG | NASDAQ
$443.44
+$11.43 (+2.65%)
Nov 2, 2026, 1:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 10.06B | 8.35B | 7.12B | 6.22B | 5.71B | 4.36B |
Cost of Revenue | 3.42B | 2.72B | 2.39B | 2.03B | 1.75B | 1.5B |
Gross Profit | 6.64B | 5.63B | 4.73B | 4.2B | 3.96B | 2.86B |
Operating Income | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B | 1.05B |
Interest Income | 365.9M | 324.9M | 192.1M | 29.7M | 69.3M | 157.2M |
Pretax Income | 3.31B | 2.67B | 1.96B | 1.61B | 1.89B | 1.21B |
Net Income | 2.86B | 2.32B | 1.8B | 1.32B | 1.7B | 1.06B |
Selling & General & Admin | 2.39B | 2.14B | 1.96B | 1.74B | 1.47B | 1.22B |
Research & Development | 1.31B | 1.15B | 998.8M | 879M | 671M | 595.1M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.7B | 3.29B | 2.96B | 2.62B | 2.14B | 1.81B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.12B | 6B | 5.36B | 4.65B | 3.89B | 3.31B |
Income Tax Expense | 434.8M | 336.3M | 141.6M | 262.4M | 162.2M | 140.2M |
Shares Outstanding (Basic) | 356.9M | 355.2M | 351.2M | 355.7M | 356.1M | 351M |
Shares Outstanding (Diluted) | 362.7M | 362M | 357.4M | 362M | 365.8M | 360.9M |
EPS (Basic) | 8 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 |
EPS (Diluted) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 |
EBITDA | 3.99B | 3.14B | 2.41B | 1.97B | 2.2B | 1.33B |
EBIT | 3.31B | 2.67B | 1.96B | 1.61B | 1.89B | 1.05B |
Depreciation & Amortization | 677.1M | 462M | 454.8M | 365.8M | 310.2M | 276.2M |
Add to Watchlist
Select watchlists to add or remove ISRG